AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05294679 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Propofol
Description: All patients completed pre-anaesthesia assessment, signed informed consent, and completed vital signs on the day before surgery, with values as baseline vital signs. On the day of surgery, after routine preparation before colonoscopy (fasting for at least 6h and water restriction for at least 2h before surgery), venous access was established in the left hand. 0.5μg/kg fentanyl was administered intravenously after oxygen inhalation through a nasal catheter (4-6 L/min). About 3 minutes after fentanyl administration, sedation induction was performed with ciprofol or propofol immediately.
Study NCT05294679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ciprofol
Description: Ciprofol
Study NCT05579431 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-634
Description: Suspension for oral administration.
Study NCT05579431 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Suspension for oral administration.
Study NCT04914234 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atenolol Succinate Oral Tablet
Description: Atenolol 50 mg
Study NCT04914234 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metoprolol Succinate Oral Tablet
Description: Metoprolol 100 mg
Study NCT05254041 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Menstrual Cup Removal
Description: Participants will be asked to remove Menstrual cup by breaking the seal.
Study NCT06550440 — intervention group
Intervention type: BEHAVIORAL
Intervention: family integrated care
Description: Trained NICU nurses give effective education to parents of children, and regard parents as a part of NICU team, so that they can actively provide positive care for babies instead of passive caregivers. Parents mainly participate in nursing care such as bottle feeding, changing diapers, skin contact and so on.
Study NCT05153629 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENS
Description: TENS device used four times a day for 60 minutes each time
Study NCT04758715 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Food provided from a commercial meal service provider for a week
Description: Meals from a commercial meal service provider provide for a week to participant
Study NCT06647966 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PET/CT
Description: \[11C\]CH PET/CT
Study NCT06652581 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Modified Thorachoabdominal Nerve Block Perichondrial Approach(M-TAPA
Description: USG Guided Bilateral Modified Thorachoabdominal Nerve Block Perichondrial Approach (M-TAPA) using 20 ml Bupivacaine 0,25%.
Study NCT06652581 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Opioid Intravena
Description: Opioid Intravenous post Surgery without M-TAPA Block delivered with PCA Machine
Study NCT06652906 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium phosphate powder
Description: After admission, the patient underwent comprehensive renal function and electrolyte tests. The first medication was taken at 7pm the day before the examination. One bag of sodium phosphate powder was diluted with 800ml or more of warm and cool water before taking. The second dose of medication should be taken at 7am on the day of operation or examination (or at least 3 hours before the examination), with the same usage as the first dose, with a 12 hour interval between each dose. The standard dose for each dose is 1 bag, until clear water like stool appears.
Study NCT06652906 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Polyethylene glycol electrolyte dispersion
Description: After admission, the patient underwent comprehensive renal function and electrolyte examination. The evening before the intestinal examination, 2000ml of polyethylene glycol electrolyte San III isotonic solution was taken, 250ml every 10-15 minutes, and it was taken within 2 hours. On the day of examination, 2000ml of polyethylene glycol electrolyte San III isotonic solution was taken 3-4 hours in advance until clear water like stool appeared.
Study NCT04723329 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-based exercise training based on the transtheoretic model
Description: Motivating interviews will be provided to the patients to receive training on the website by contacting them one-on-one. In the following 1st and 3rd months, patients will be contacted individually again to confirm whether they follow the website, and they will be asked to fill in the scales on the website by providing consultancy on the issues they need. In the 6th month, the final test data will be obtained from the website using the same data collection forms.
Study NCT06377774 — intervention group
Intervention type: OTHER
Intervention: No intervention in this study
Description: No intervention in this study
Study NCT04502537 — intervention group
Intervention type: DRUG
Intervention: Roxadustat
Description: Oral
Study NCT04502537 — intervention group
Intervention type: DRUG
Intervention: erythropoietin
Description: injection
Study NCT05716074 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supervised exercise
Description: The supervised group will be given 10 minutes of warm-up, 10 minutes of breathing exercises, 20 minutes of low endurance combined exercises (stretching, strengthening, strength exercises), 10 minutes of balance and walking training, and 10 minutes of cool-down exercises. Exercise will be applied for 1 hour a day, 3 days a week for 6 weeks.
Study NCT05716074 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home exercise
Description: The home group will be given 10 minutes of warm-up, 10 minutes of breathing exercises, 20 minutes of low endurance combined exercises (stretching, strengthening, strength exercises), 10 minutes of balance and walking training, and 10 minutes of cool-down exercises. Exercise will be applied for 1 hour a day, 3 days a week for 6 weeks in the home.
Study NCT05612308 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vertical Oscillatory Pressure (VOP)
Description: The VOP involves a pressure from the posterior aspect of the body while patient lye prone. the pressure is exacted directly on the spine, The sustained Natural Apophyseal Glides involves pressure as well when the patient sits down on a chair. The movement is done from the posterior to the anterior as well
Study NCT04931693 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paracetamol
Description: iv post operative analgesia
Study NCT04931693 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: modifiedPECs block
Description: sonar guided pectoral nerve block
Study NCT05854355 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: C-SLAMM Study
Description: The intervention arm includes using innovative behavioural, pedagogical, and environmental strategies within the classroom, school, and home settings to get children moving more and sitting less. The strategies were based on strategies used in Transform-Us! involved incorporating movement into everyday class lessons - the delivery of the lesson changes, not the content. Resources included health lessons, active lessons, active breaks, active homework to do with parents, active environments, and newsletters for parents.
Study NCT04892264 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Belantamab Mafodotin
Description: Given IV
Study NCT04892264 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Given IV
Study NCT04892264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given PO
Study NCT04892264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given PO
Study NCT04892264 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT04892264 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06286995 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Chemomechanical preparation for root canals
Description: After working length determination ,root canal preparation was made by two different NiTi File systems to both group ( the first group using Trunatomy file and the second one using edgeendo x7 file) and assessment of pain was made preoperatively and postoperatively and also apical fluid samples
Study NCT04892264 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Skeletal Survey X-Ray
Description: Undergo X-ray skeletal survey
Study NCT04892264 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low Dose Computed Tomography of the Whole Body
Description: Undergo whole body low dose CT
Study NCT06566547 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GR1803 injection
Description: D1 given at a dose of 30ug/kg, D4 given at a dose of 90ug/kg, D8 given at a dose of 180ug/kg, followed by weekly dosing up to cycle 9, and cycle 10 and onwards, every 2 weeks, with a dosing cycle of every 4 weeks
Study NCT04892264 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration and biopsy
Study NCT04892264 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow aspiration and biopsy
Study NCT06333379 — intervention group
Intervention type: OTHER
Intervention: Compare the levels of Galactomannan (GM) levels in exhaled breath condensate (EBC) and BALF
Description: Investigators tested EBC-GM levels and BALF-GM levels in patients with confirmed IPA to compare the diagnostic value of EBC-GM versus BALF-GM.
Study NCT05580432 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Parenting with Positive Behavior Interventions
Description: Parenting with Positive Behavior Interventions is a 5 month packaged intervention. The curriculum and each element of the training and coaching program is described in detail below.~Each month, participants will participate in the following five activities:~1. Didactic Training: Participants will view a presentation~2. Workbook/Homework: Participants will complete a guided worksheet~3. Coaching Meeting - Planning: Participants will meet with a coach who is an expert in autism and behavior~4. Coaching - Observation/ Feedback: The coach will observe parent implementing the strategy, then provide feedback and direction regarding use of technique~5. Virtual Parent Community of Support Meeting: Attend parent led community support meeting to network, share experiences and information, and exchange ideas
Study NCT05774639 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omalizumab Injection
Description: ADL-018 (Omalizumab) solution for injection 150 mg/mL prefilled syringe (PFS)
Study NCT05774639 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xolair Prefilled Syringe
Description: XOLAIR (omalizumab) injection is supplied as a single dose PFS. Each PFS of XOLAIR contains 150 mg of omalizumab in 1 mL of solution
Study NCT05774639 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Xolair Prefilled Syringe
Description: XOLAIR (omalizumab) injection is supplied as a single dose PFS. Each PFS of XOLAIR contains 150 mg of omalizumab in 1 mL of solution
Study NCT05607524 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: probiotics
Description: Eat a capsule for once, and twice a day
Study NCT05607524 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Eat a capsule for once, and twice a day
Study NCT05549011 — intervention group
Intervention type: OTHER
Intervention: PENG Block
Description: PENG block for analgesic purposes performed before hip surgery
Study NCT05549011 — intervention group
Intervention type: OTHER
Intervention: SIFI compartment block
Description: SIFI compartment block for analgesic purposes performed before hip surgery
Study NCT05549011 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Numeric Rating Scale
Description: Self-reported pain intensity score between 0-10
Study NCT05549011 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Angle of sitting
Description: Measurement of sitting angle in degrees with a protractor
Study NCT05906862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMT-253
Description: Administered intravenously
Study NCT05580432 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parenting with Positive Behavior Interventions
Description: Parenting with Positive Behavior Interventions is a 5 month packaged intervention. The curriculum and each element of the training and coaching program is described in detail below.~Each month, participants will participate in the following five activities:~1. Didactic Training: Participants will view a presentation~2. Workbook/Homework: Participants will complete a guided worksheet~3. Coaching Meeting - Planning: Participants will meet with a coach who is an expert in autism and behavior~4. Coaching - Observation/ Feedback: The coach will observe parent implementing the strategy, then provide feedback and direction regarding use of technique~5. Virtual Parent Community of Support Meeting: Attend parent led community support meeting to network, share experiences and information, and exchange ideas
Study NCT06586658 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-CD70-CAR-T cells
Description: The subjects received infusions of anti-CD70 CART cells following completion of lymphodepleting preconditioning chemotherapy. Dosage: 3×10\^6 cells/Kg; 1×10\^7 cells/Kg; 2×10\^7 cells/Kg.
Study NCT06651203 — intervention group
Intervention type: OTHER
Intervention: Follow-up
Description: Clinical evaluation Blood sample Skin biopsy
Study NCT06653374 — intervention group
Intervention type: BEHAVIORAL
Intervention: Infant, Premature
Description: This intervention is distinct as it focuses specifically on observational monitoring and evaluation of neonatal outcomes without applying a therapeutic or procedural treatment. Unlike other interventional studies, the emphasis is on analyzing standard care practices, risk factor exposures (e.g., prematurity, maternal complications), and their impact on neonatal morbidity and mortality. The intervention involves systematic data collection and longitudinal follow-up to identify patterns and associations, rather than introducing new clinical techniques or treatment
Study NCT06651762 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: unilateral Radiofrequency
Description: unilateral genicular nerve cooled radio frequency ablation pre-operative
Study NCT06651762 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: bilateral Radiofrequency
Description: bilateral genicular nerve cooled radio frequency ablation pre-operative
Study NCT06651762 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Epidural
Description: Patients will receive epidural anesthesia intra operative and epidural analgesia post-operative
Study NCT06641856 — intervention group
Intervention type: OTHER
Intervention: Sample Collection
Description: All participants will provide nasal and pharyngeal swabs for virome analysis. A subset of 30 elderly volunteers will also provide peripheral blood samples and undergo bronchoscopy under general anesthesia to collect upper and lower respiratory tract samples.
Study NCT06499701 — intervention group
Intervention type: DRUG
Intervention: Ringer's Lactate
Description: Ringer's Lactate is administered at a dose of 30ml/kg, with the first 20ml/kg given at a constant rate over the initial 30 minutes, followed by a 30-minute pause, and then an additional 10ml/kg over the next 15 minutes, completing the infusion within 75 minutes.
Study NCT05027308 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teduglutide
Description: Teduglutide 0.05 mg/kg SC injection
Study NCT05388942 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Virtual reality hypnosis
Description: VRH offers predefined hypnosis sessions with no need of trained physician or nurse or caregiver mobilization. Consisting of a headset including headphones and a virtual reality screen, VRH allow patients to select a visual and sound environment (e.g.: tropical beach, space, underwater...) into which the hypnotic speech is delivered. That way, the patient's attention is distracted and muscular relaxation is obtained, a major relaxation factor. HRV is simple, quick, and presumably safe.
Study NCT05388942 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrous oxide
Description: inhalation of NO usually used to help with ASD reduction but inhaled NO has safety and maintenance issues.
Study NCT06439979 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RAYS Intervention
Description: Developmental baseball leagues will be randomly assigned to RAYS vs. control. Outcomes include directly-observed child sun safety behaviors after controlling for environmental ultra-violet radiation (UVR), with parent-reported child sun protection and other related endpoints at 1 year.
Study NCT04971564 — intervention group
Intervention type: OTHER
Intervention: Blood sampling
Description: Blood sampling will be made to Day 0, Day 3 and to 3 month after inclusion
Study NCT06007014 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chiglitazar sodium
Description: tablets 48mg/ day administered for 18 weeks
Study NCT06007014 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Chiglitazar placebo
Description: tablets 48mg/ day administered for 18 weeks
Study NCT05614245 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VBI-2901e
Description: Intramuscular injection of VBI-2901e, an investigational trivalent coronavirus vaccine that contains three coronavirus spike proteins with aluminum phosphate and E6020 adjuvants
Study NCT05060393 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy
Description: Mobile application, mindfulness-based therapy
Study NCT04999631 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Squaric Acid Dibutyl Ester
Description: Topical squaric acid dibutyl ester (SADBE) dissolved in ethanol at 0.2% concentration.
Study NCT04999631 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ethanol Solution
Description: Control
Study NCT05470439 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: My Interprofessional Care team for Adherence and Research Engagement (MI-CARE)
Description: MI-CARE is an innovative, tailored coordinated care intervention by pharmacist-community health worker (CHW) team derived from a previous research and a clinical pilot implementation. MI-CARE will identify and address individual, clinical, social-cultural and structural barriers to medication adherence and hypertension management. MI-CARE consists of an initial individualized needs assessment (Baseline). During Months 1-2, pharmacist-CHW team will deliver a tailored intervention including an individualized medication chart, preferred adherence aids, hypertension therapy optimization, tailored education based on medication beliefs, tools to combat social stressors, and referrals for structural barriers such as food insecurity, transportation and drug costs. Tailored family/care partner participation and telehealth visits will be provided when needed during this time. A booster visit to assess patient progress and reinforce intervention components will occur at Month 2.
Study NCT06168526 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acute physical activity
Description: Regarding the first aim, participants will go through five different conditions using a within-participants cross-over design in a randomized order: control group (quietly sitting), light intensity (40% VO2max), moderate intensity (63% VO2max), or vigorous intensity (100% VO2max) exercise. All conditions will last 16 minutes and 15 seconds. The exercise conditions will be organized following an interval protocol, which includes 22 bouts of 30 seconds running at the established intensity with 15 seconds of passive rest between bouts. In addition, to achieve the second aim, the active break will be designed taking into account the intensity of physical activity that proves to have the greatest benefits on cognition and well-being.
Study NCT04505020 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D Print + Conventional imaging
Description: This group will have a 3D reconstruction of their hip printed using a 3D printer so that the PI can use it in their pre and intra-operative planning along with traditional imaging.
Study NCT04505020 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional imaging
Description: This group will have CT, MRI and X-Ray imaging completed so that the PI can use it in their pre and intra-operative planning.
Study NCT04431362 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-selected music
Description: Participants will be given iPods and headphones to listen to their music
Study NCT04099862 — intervention group
Intervention type: PROCEDURE
Intervention: ERCP
Description: Endoscopic retrograde cholangiopancreatography (ERCP)
Study NCT04099862 — intervention group
Intervention type: PROCEDURE
Intervention: EUS-BD
Description: Endoscopic UltraSound Biliary Drainage
Study NCT06091553 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine alone
Description: 30 mg once daily for 1 week, then 60 mg once daily
Study NCT06443216 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Auditory closed-loop stimulation
Description: Auditory closed-loop suppression of slow wave sleep
Study NCT06443216 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham stimulation
Description: No auditory stimulation
Study NCT06091553 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine augmented with gabapentin
Description: 30 mg once daily for 1 week, then 60 mg once daily 300 mg at bedtime
Study NCT06091553 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine augmented with amitriptyline (as combined therapy)
Description: 10 to 25 mg once daily at bedtime 30 mg once daily for 1 week, then 60 mg once daily